← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2020Last known activity
Dec 31, 2025
Timeline
2010s
- Jun 1, 2017
Zhejiang Genfleet Therapeutics Co., Ltd.— Founded
Drugs by trial phase (15 distinct, 18 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (18)
- NCT07262567Lead sponsorPhase 3Dec 31, 2025
- NCT07259590Lead sponsorPhase 1/Phase 2Oct 21, 2025
- NCT07198321Lead sponsorPhase 1/Phase 2Sep 22, 2025
- NCT07026916Lead sponsorPhase 2Aug 31, 2025
- NCT06898255Lead sponsorPhase 1Apr 24, 2025
- NCT06500676Lead sponsorPhase 1/Phase 2Jul 9, 2024
- NCT06375733Lead sponsorPhase 1/Phase 2Mar 20, 2024
- NCT05934513Lead sponsorPhase 1/Phase 2Sep 15, 2023
- NCT05756153Lead sponsorPhase 1/Phase 2Apr 25, 2023
- NCT05618691Lead sponsorPhase 2Dec 1, 2022
- NCT05991362Lead sponsorPhase 1Nov 29, 2022
- NCT05386888Lead sponsorPhase 2Sep 1, 2022
- NCT05165849Lead sponsorPhase 1/Phase 2Apr 30, 2022
- NCT05051241Lead sponsorPhase 1Sep 30, 2021
- NCT05005234Lead sponsorPhase 1/Phase 2Sep 10, 2021
Details
- Founded
- Shanghai, CN Jun 1, 2017
- Last known activity
- Dec 31, 2025